Olfactomedin 1 was also reported to suppress the cleavage of amyloid precursor protein and inhibit the subsequent production of amyloid-beta, the main contributor to Alzheimer's disease (Takahama et al., 2004). Here, APP is linked to early-onset autosomal dominant Alzheimer disease.